Rejected at 6:34 p.m. Jan, 22, 2024 ] by herstein.jacob
Author: patfan09
Co-authors: Ahmed7
Related Note: 1474340761077
Rationale for change

FA 2023 page 692.4 (Deep venous thrombosis) now says to use direct anticoagulants (eg, rivaroxoban, apixaban) for treatment and long-term prevention

Rejection reason

dupe suggestion

Text Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Picmonic
Empty field
Pixorize
Empty field
Physeo
Empty field
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#Low/HighYield::1-HighYield #PANCE::EOR::Family_med #AK_Step2_v12::#B&B::14_Pulmonary_Critical_Care::03_Other::02_DVT_and_Pulmonary_Embolism #AK_Step1_v12::#SketchyPath::03_Pulmonary::03_Acute_Lung_Disorders::03_Deep_Vein_Thrombosis_&_Pulmonary_Embolism #AK_Step1_v12::^Systems::Respiratory::Pathology #AK_Step1_v12::#FirstAid::16_Respiratory::04_Pathology::04_Deep_venous_thrombosis::*DVT #AK_Step1_v12::#SketchyPharm::03_Blood_&_Inflammation::01_Anticoagulants_&_Thrombolytics::01_Heparin,_LMWH,_fondaparinux,_direct_thrombin_inhibitors,_Xa_inhibitors #AK_Step2_v12::#B&B::02_Cardio::01_Arrhythmias::03_Atrial_Fibrillation_and_Flutter::Extra #AK_Step1_v12::#AMBOSS::VkaG5k #PANCE::CARDIO::vascular_disease #AK_Step1_v12::#OME::Clinical::Internal_Medicine::Hematology-Oncology::Approach_To_Bleeding #PANCE::EOR::IM #AK_Step1_v12::#Bootcamp::Pulmonology::08_Lung_Pathology_Special_Topics::01_DVT_and_Pulmonary_Embolism #AK_Other::Only_Step_1&2_Overlap #AK_Step1_v12::#B&B::20_Pulm::03_Other_Pulmonary_Topics::10_Deep_Vein_Thrombosis_&_Pulmonary_Embolism::Extra #AK_Step2_v12::#B&B::07_Hematology_and_Oncology::02_Coagulation::05_Anticoagulants::Extra #AK_Other::#AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Respiratory::Respiratory_Pathology #AK_Step2_v12::#SketchyIM::01_Cardiology::05_Blood_Vessel_Disease::01_DVT_SOAP #PANCE::EOR::EM #AK_Step2_v12::#AMBOSS::tsaX9N #AK_Step1_v12::#NinjaNerd::09_Hematology::02_Pathology::17_Hypercoagulable_States #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::07_Coagulation_and_Fibrinolysis::10_Anticoagulation #AK_Step1_v12::#B&B::12_Hematology::01_Hemostasis::07_Anticoagulant_Drugs::Extra #AK_Step1_v12::#NinjaNerd::09_Hematology::02_Pathology::15_Antiplatelets,_Anticoagulants,_and_Thrombolytics #AK_Step2_v12::#FirstAid::14_Pulm::04_Pulmonary_Vascular_Disease::02_Pulmonary_Thromboembolism #AK_Step1_v12::#NinjaNerd::04_Pharmacology::01_Basics::03_Antiplatelet,_Anticoagulant,_Thrombolytic_Agents #AK_Step2_v12::#SketchyIM::08_Hematology_&_Oncology::01_Bleeding_&_Clotting_Disorders::03_Hypercoagulable_Disorders_DDx #AK_Step1_v12::#Pathoma::04_Hemostasis::04_Thrombosis